Literature DB >> 17376435

Finding diamonds in the rubble.

Jang-Ho J Cha1.   

Abstract

Mesh：

Year:  2007        PMID： 17376435      PMCID： PMC1934616          DOI： 10.1016/j.expneurol.2007.02.003

Source DB:  PubMed          Journal:  Exp Neurol        ISSN： 0014-4886            Impact factor:   5.330


× No keyword cloud information.
  25 in total

Review 1.  5-hydroxytryptamine (5-HT, serotonin) and Parkinson's disease - opportunities for novel therapeutics to reduce the problems of levodopa therapy.

Authors:  S L Nicholson; J M Brotchie
Journal:  Eur J Neurol       Date:  2002-11       Impact factor: 6.089

Review 2.  Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective.

Authors:  Rudolph E Tanzi; Lars Bertram
Journal:  Cell       Date:  2005-02-25       Impact factor: 41.582

3.  Transcriptional changes in multiple system atrophy and Parkinson's disease putamen.

Authors:  Ina R Vogt; Andrew J Lees; Bernd O Evert; Thomas Klockgether; Michael Bonin; Ullrich Wüllner
Journal:  Exp Neurol       Date:  2006-04-19       Impact factor: 5.330

Review 4.  Genetics of Parkinson disease: paradigm shifts and future prospects.

Authors:  Matthew James Farrer
Journal:  Nat Rev Genet       Date:  2006-04       Impact factor: 53.242

Review 5.  Animal models of multiple system atrophy.

Authors:  Nadia Stefanova; François Tison; Markus Reindl; Werner Poewe; Gregor K Wenning
Journal:  Trends Neurosci       Date:  2005-09       Impact factor: 13.837

6.  Expression profiling of substantia nigra in Parkinson disease, progressive supranuclear palsy, and frontotemporal dementia with parkinsonism.

Authors:  Michael A Hauser; Yi-Ju Li; Hong Xu; Maher A Noureddine; Yujun S Shao; Steven R Gullans; Clemens R Scherzer; Roderick V Jensen; Adam C McLaurin; Jason R Gibson; Burton L Scott; Rita M Jewett; Judith E Stenger; Donald E Schmechel; Christine M Hulette; Jeffery M Vance
Journal:  Arch Neurol       Date:  2005-06

7.  Decreased expression of striatal signaling genes in a mouse model of Huntington's disease.

Authors:  R Luthi-Carter; A Strand; N L Peters; S M Solano; Z R Hollingsworth; A S Menon; A S Frey; B S Spektor; E B Penney; G Schilling; C A Ross; D R Borchelt; S J Tapscott; A B Young; J H Cha; J M Olson
Journal:  Hum Mol Genet       Date:  2000-05-22       Impact factor: 6.150

Review 8.  Neuropeptides and their receptors: innovative science providing novel therapeutic targets.

Authors:  Susan D Brain; Helen M Cox
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

9.  Increased neuropeptide Y mRNA expression in striatum in Parkinson's disease.

Authors:  Carla Cannizzaro; Banu C Tel; Sarah Rose; Bai-Yun Zeng; Peter Jenner
Journal:  Brain Res Mol Brain Res       Date:  2003-02-20

10.  Regional and cellular gene expression changes in human Huntington's disease brain.

Authors:  Angela Hodges; Andrew D Strand; Aaron K Aragaki; Alexandre Kuhn; Thierry Sengstag; Gareth Hughes; Lyn A Elliston; Cathy Hartog; Darlene R Goldstein; Doris Thu; Zane R Hollingsworth; Francois Collin; Beth Synek; Peter A Holmans; Anne B Young; Nancy S Wexler; Mauro Delorenzi; Charles Kooperberg; Sarah J Augood; Richard L M Faull; James M Olson; Lesley Jones; Ruth Luthi-Carter
Journal:  Hum Mol Genet       Date:  2006-02-08       Impact factor: 6.150
View more
  1 in total

Review 1.  Beyond the rat models of human neurodegenerative disorders.

Authors:  Ondrej Bugos; Mangesh Bhide; Norbert Zilka
Journal:  Cell Mol Neurobiol       Date:  2009-03-05       Impact factor: 5.046
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.